Custom recombinant protein production is one of the efficient techniques used in life sciences that play a major role in advanced healthcare. Recombinant proteins have a wide range of applications in biotechnology, research, and medicine. Increasing funding in the field of life sciences is expected to accelerate growth of the custom recombinant protein production services market. The importance of recombinant protein for therapeutic application is increasing immensely. Various biopharmaceutical companies are focusing on research and development of novel biosimilars for life threatening diseases. Proteins are manipulated using specified techniques to derive recombinant proteins, these recombinant proteins are encoded by genes for the production of large quantities of protein. Recombinant proteins are further used for the manufacturing of therapeutic commercial products. Technological advancement in the production of recombinant protein is predicted to boost growth of the market.
Market Dynamics
Increasing funding and investments in the field of life sciences are expected to drive the market growth during the forecast period. For instance, additional funding of US$ 3.0 million was received by Oxford Protein Production Facility-UK from the Laboratory of Molecular Biology for providing a wide range of highly specialized technologies that incorporates robotic systems for high throughput purification, expression, and crystallization of recombinant proteins.
Key features of the study:
- The report provides an in-depth analysis of the Custom Recombinant Protein Production Services market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the custom recombinant protein production services market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies
- Key companies covered as a part of this study include GenScript Biotech Corporation, SignalChem Biotech Inc., Crown Bioscience, Inc., BPS Bioscience Inc., Novoprotein, Applied Biological Materials (abm) Inc., Eurofins Pharma Discovery Services, Abgent (WuXi AppTec Company), OriGene Technologies, Inc., Kempbio, Inc., Trenzyme GmbH, Sino Biological Inc., Aragen Bioscience, a GVKBIO Company, LakePharma, Inc., Proteos Inc., Icosagen AS, Novus Biological LLC, Proteogenix, Premas Biotech, ATUM, and Aldevron
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The custom recombinant protein production services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the custom recombinant protein production services market
Detailed Segmentation:
- Custom Recombinant Protein Production Services Market, By Expression System:
- Mammalian
- Bacteria
- Insect
- Yeast
- Others
- Custom Recombinant Protein Production Services Market, By End User:
- Research Institutes
- Biotechnology and Pharmaceutical Companies
- Contract Research Organizations
- Others
- Custom Recombinant Protein Production Services Market, By Region:
- North America
- By Expression System
- Mammalian
- Bacteria
- Insect
- Yeast
- Others
- , By End User
- Research Institutes
- Biotechnology and Pharmaceutical Companies
- Contract Research Organizations
- Others
- By Country
- Latin America
- By Expression System
- Mammalian
- Bacteria
- Insect
- Yeast
- Others
- , By End User
- Research Institutes
- Biotechnology and Pharmaceutical Companies
- Contract Research Organizations
- Others
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Expression System
- Mammalian
- Bacteria
- Insect
- Yeast
- Others
- , By End User
- Research Institutes
- Biotechnology and Pharmaceutical Companies
- Contract Research Organizations
- Others
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Expression System
- Mammalian
- Bacteria
- Insect
- Yeast
- Other
- By End User
- Research Institutes
- Biotechnology and Pharmaceutical Companies
- Contract Research Organizations
- Others
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Expression System
- Mammalia
- Bacteria
- Insect
- Yeast
- Others
- , By End User
- Research Institutes
- Biotechnology and Pharmaceutical Companies
- Contract Research Organizations
- Others
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Expression System
- Mammalian
- Bacteria
- Insect
- Yeast
- Others
- , By End User
- Research Institutes
- Biotechnology and Pharmaceutical Companies
- Contract Research Organizations
- Others
- By Country/Region
- South Africa
- Central Africa
- North Africa
- Company Profiles
- GenScript Biotech Corporation *
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- SignalChem Biotech Inc.
- Crown Bioscience, Inc.
- BPS Bioscience Inc.
- Novoprotein
- Applied Biological Materials (abm) Inc.
- Eurofins Pharma Discovery Services
- Abgent (WuXi AppTec Company)
- OriGene Technologies, Inc.
- Kempbio, Inc.,
- Trenzyme GmbH
- Sino Biological Inc.
- Aragen Bioscience, a GVKBIO Company
- LakePharma, Inc.
- Proteos, Inc.
- Icosagen AS
- Novous Biologicals LLC
- Proteogenix
- Premas Biotech
- ATUM
- Aldevron
“*” marked represents similar segmentation in other categories in the respective section.
